Adverse events: hair loss · SSNS in children
Intravenous showed no clear difference in adverse events: hair loss compared with oral cyclophosphamide (low certainty).
1 finding from 1 review
Adverse events: all infections · SSNS in children
Intravenous may leads to lower adverse events: all infections compared with oral cyclophosphamide (low certainty).
1 finding from 1 review
Adverse event nausea and vomiting (0 to 24 hours) · SSNS in children
It is very uncertain whether intravenous changes adverse events: nausea and vomiting compared with oral cyclophosphamide (very low certainty).
1 finding from 1 review
Birthweight (g) · opiate‐dependent pregnant women
1 finding from 1 review
APGAR score (APGAR score ) · opiate‐dependent pregnant women
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events for the mother · opiate‐dependent pregnant women
1 finding from 1 review
Serious adverse events for the child · opiate‐dependent pregnant women
1 finding from 1 review
Unacceptability of treatment (dropouts/exclusions during the trial) · opiate‐dependent pregnant women
1 finding from 1 review
Use of substance · opiate‐dependent pregnant women
Methadone showed no clear difference in use of substance compared with oral slow‐release morphine (low certainty).
1 finding from 1 review
Live birth rate · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical pregnancy rate · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
Transdermal oestrogens showed no clear difference in clinical pregnancy rate compared with oral oestrogens (low certainty).
1 finding from 1 review
Miscarriage · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
Transdermal oestrogens showed no clear difference in miscarriage rate compared with oral oestrogens (low certainty).
1 finding from 1 review
Multiple pregnancy rate · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cycle cancellation rate · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Endometrial thickness (mm) · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse effects · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Uterine fibroid‐related symptoms (abnormal uterine bleeding, measured at 12 weeks, with the pictorial blood assessment chart (PBAC); lower = better) · women with uterine fibroids
2 findings from 1 review
Adverse events (spotting at 3 and 6 months) · women with uterine fibroids
1 finding from 1 review
Haemoglobin level ‐ Haemoglobin level at 12 months Scale from: 0 to 20. · women with uterine fibroids
1 finding from 1 review
Fibroid size · women with uterine fibroids
1 finding from 1 review